Ozempic Slows Kidney Disease, Novo Nordisk Study Finds
Novo Nordisk’s Ozempic drug slows the progression of chronic kidney disease and cuts the risk of kidney failure, heart attack, stroke and death in patients with type 2 diabetes, detailed results of a long-term trial showed. #press